Back | Next |
home / stock / pfnx / pfnx message board
Subject | By | Source | When |
---|---|---|---|
Serum Institute of India Private Limited has achieved | Paullee | investorshub | 01/08/2020 1:12:30 PM |
Plus the premium I made off the contracts, | grich1 | investorshub | 12/18/2019 1:50:12 PM |
Nice check. Im in at $7 and was | grich1 | investorshub | 12/18/2019 1:46:58 PM |
And here's the reason | Paullee | investorshub | 12/18/2019 1:12:01 PM |
On a roll | Paullee | investorshub | 12/16/2019 2:53:36 PM |
On a roll | Paullee | investorshub | 12/16/2019 2:53:11 PM |
On a roll | Paullee | investorshub | 12/16/2019 2:53:09 PM |
Sweet. $12 trade alert hit today and this | grich1 | investorshub | 12/13/2019 5:36:52 PM |
great qtr, lots of interesting stuff going on | Paullee | investorshub | 11/07/2019 9:54:03 PM |
No, I only got the headline from my | Paullee | investorshub | 11/05/2019 4:40:57 AM |
Paul, do you know where i can find | dennisczy | investorshub | 11/05/2019 1:40:19 AM |
Cantor starts $PFNX with a price target of 20 | Paullee | investorshub | 10/25/2019 12:55:20 PM |
Pfenex Reports Positive Results for PF708 Comparative Use | Paullee | investorshub | 10/14/2019 12:09:35 PM |
Thats great news. I opened a position | grich1 | investorshub | 10/12/2019 2:56:45 PM |
PFenex Provides Update for PF708 Outside the United States | Paullee | investorshub | 10/11/2019 4:27:20 PM |
* * $PFNX Video Chart 10-07-2019 * * | ClayTrader | investorshub | 10/07/2019 9:37:09 PM |
whytestocks: $PFNX News Article - Pfenex Receives U.S. FDA Approval for PF708 to Treat Osteoporosis | whytestocks | investorshangout | 10/07/2019 1:50:42 PM |
News: $PFNX Pfenex Receives U.S. FDA Approval for | whytestocks | investorshub | 10/07/2019 1:50:28 PM |
http://filecache.investorroom.com/mr5ir pfenex/219/download/Corporate%20Deck%20A | grich1 | investorshub | 10/07/2019 12:09:47 PM |
whytestocks: $PFNX News Article - Pfenex to Present at the Cantor Healthcare Conference | whytestocks | investorshangout | 09/16/2019 8:15:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Pfenex Inc. (NYSE American: PFNX) at an offer price of $12.00 per share in cash, plus one non-transferable contractua...
NEW YORK, NY / ACCESSWIRE / September 15, 2020 / Juan Monteverde , founder, and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Pfenex Inc. (NYSE American: PFNX ) relating to it...
NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately s...